ctrl K

Elevation Oncology Inc. (ELEV)

NASDAQ: ELEV · Real-Time Price · USD

0.34

-0.00 (-0.03%)

At close: May 02, 2025, 12:48 PM

Elevation Oncology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	39K	27K	18K	15K	n/a
Gross Profit	n/a	-39K	-27K	-18K	-15K	n/a
Operating Income	-44.7M	-45.45M	-94.55M	-32.05M	-17.28M	-5.88M
Interest Income	n/a	3.9M	n/a	n/a	n/a	n/a
Pretax Income	-44.44M	-45.67M	-95.06M	-32.04M	-17.27M	-5.88M
Net Income	-44.48M	-45.7M	-95.08M	-32.04M	-17.27M	-5.88M
Selling & General & Admin	16.11M	14.9M	15.83M	8.45M	1.8M	544K
Research & Development	28.6M	25.43M	78.72M	23.59M	15.48M	5.34M
Other Expenses	n/a	5.11M	-506K	7K	11K	n/a
Operating Expenses	44.7M	45.45M	94.55M	32.05M	17.28M	5.88M
Interest Expense	1.2M	4.17M	479K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	543.18K
Cost & Expenses	n/a	45.45M	94.55M	32.05M	17.28M	5.88M
Income Tax Expense	43K	30K	25K	-218.56K	-191.3K	-8.82K
Shares Outstanding (Basic)	57.28M	34.08M	23.27M	23.21M	23.76M	23.76M
Shares Outstanding (Diluted)	57.28M	34.08M	23.27M	23.21M	23.76M	23.76M
EPS (Basic)	-0.78	-1.34	-4.09	-1.38	-0.73	-0.25
EPS (Diluted)	-0.78	-1.34	-4.09	-1.38	-0.73	-0.25
EBITDA	-44.7M	-41.47M	-94.52M	-32.03M	-17.25M	-5.88M
EBIT	-43.24M	-41.51M	-94.55M	-32.05M	-17.28M	-5.88M
Depreciation & Amortization	-1.46M	39K	27K	18K	15K	3.57M